Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Clinical trial NCT02548195 · UNKNOWN

Trial details

NCT number: NCT02548195
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2015-07-01
Primary completion: 2018-06-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.